First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-Year follow-up of the phase III CheckMate 649 trial Journal Article
| Authors: | Janjigian, Y. Y.; Ajani, J. A.; Moehler, M.; Shen, L.; Garrido, M.; Gallardo, C.; Wyrwicz, L.; Yamaguchi, K.; Cleary, J. M.; Elimova, E.; Karamouzis, M.; Bruges, R.; Skoczylas, T.; Bragagnoli, A.; Liu, T.; Tehfe, M.; Zander, T.; Kowalyszyn, R.; Pazo-Cid, R.; Schenker, M. |
| Article Title: | First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 3-Year follow-up of the phase III CheckMate 649 trial |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 17 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Start Page: | 2012 |
| End Page: | 2020 |
| Language: | English |
| DOI: | 10.1200/jco.23.01601 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PMCID: | PMC11185916 |
| PUBMED: | 38382001 |
| DOI/URL: | |
| Notes: | Accession Number: 177717042 -- Entry Date: In Process -- Revision Date: 20240610 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: CINAHL Plus with Full Text |
